Bluebird bio (BLUE) Competitor Comparison
We are evaluating the key criteria listed to compare Bluebird bio (BLUE) against its competitors in the Biotechnology industry.
Market Capitalization
191 / 377Gross Profits
272 / 285Total Revenue
163 / 309EBITDA
242 / 345Free Cashflow
308 / 361Quick Ratio
326 / 366Earnings per Share
88 / 367Dividend yield
0 / 5Total Cash
172 / 367Performance 3 years
356 / 377Performance 5 years
370 / 377Performance 10 years
312 / 377Linearity 3 years
311 / 377Linearity 5 years
301 / 377Linearity 10 years
50 / 377Total Rank
280 / 377Dividend Rank
71 / 377Valuation Rank
195 / 377Piotroski Rank
116 / 377Muliplier Rank
65 / 377Total Cash - BLUE ranking 172 / 367
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.